Cardiff Oncology, Inc. (CRDF) has seen some recent volatility in the market and its common shares closed trading at $14.65 yesterday. People are starting to take notice of CRDF as the common shares traded as high as $15.49 and as low as $14.36 in the last market trading day.

Cardiff Oncology, Inc. (CRDF) average trading volume is 2.09M. However, in the last market trading day Cardiff Oncology, Inc. (CRDF) traded 885,435 shares. The First support level on CRDF is $14.61 and the First upside resistance level on CRDF is $18.96. CRDF 50day moving average is $10.38 and CRDF 200day moving average is $5.50.

Cardiff Oncology, Inc. (CRDF) most recent performance has been specified by the recent movement in CRDF common shares. CRDF has performed 152.15% over the past 30 days, CRDF has performed 223.40% over the past quarter and CRDF has shown 1295.24% over the past year. Cardiff Oncology, Inc. (CRDF) has a 52 week range of $0.70 to $18.12. Cardiff Oncology, Inc. (CRDF) is trading 1989.87% from its 52 week low and -19.16% from its 52 week high. Cardiff Oncology, Inc. (CRDF) is indicating a 5.87% short float indicating the amount short in the float.

CRDF has 31.50M shares outstanding and 16.25M shares in the float. Cardiff Oncology, Inc. (CRDF) currently has a market cap of $443.31M and income of -19.90M. The EPS next quarter for CRDF is -0.21 and anticipated EPS next year is 34.50%. The market cap of Cardiff Oncology, Inc. (CRDF) at $443.31M represents how many People own shares of CRDF and is calculated off the last price ($14.65) of CRDF and the amount of shares outstanding (31.50M) with Cardiff Oncology, Inc. (CRDF).

Cardiff Oncology, Inc. (CRDF) has total cash (mrq) of 27.75M, total cash per share (mrq) of 1.2, total debt of CRDF remains at 1.61M and total debt/equity (mrq) is 6.61. . Cardiff Oncology, Inc. (CRDF) running cash flow (ttm) is -14.13M, CRDF leveraged free cash flow (ttm) is -7.94M.

CRDF is trading 11.46% above (bullish) its SMA20, 59.82% above (bullish) its SMA50 and 271.20% above (bullish) its SMA200.